Angelo Antonini, MD, PhD

Professor – Department of Neuroscience
Parkinson and Movement Disorders Unit, Department of Neuroscience, University of Padova, Italy

Poster(s):

• (85) Efficacy and safety of fixed-dose tavapadon, an oral, once-daily, selective D1/D5 dopamine agonist for the treatment of early Parkinson’s disease
  Wednesday, October 29, 2025